The Zhitong Finance App learned that pharmaceutical stocks were generally lower, with the CRO concept falling the highest. As of press release, Kingsley Biotech (01548) fell 16.04% to HK$35.38; Kanglong Chemical (03759) fell 7.86% to HK$28.14; Tiger Pharmaceuticals (03347) fell 6.93% to HK$41.92; Rongchang Biotech (09995) fell 4.55% to HK$67.1.

According to the news, Hong Kong stock innovative drugs are interest rate sensitive assets, and market performance is affected by the Federal Reserve's trends. Cleveland Federal Reserve Chairman Hammark said that smaller and more frequent monetary policy adjustments will help keep inflation expectations stable. It is better than waiting now, and risks requiring larger policy adjustments in the future.

From October 6 to October 12, the US stock AI pharmaceutical company Twist surged higher and then retreated by more than 25%. Societe Generale Securities believes that in the short term, the AI4S long-term industry trend is still promising due to the phased pullback of US stock benchmarking companies. The bank said that demand for AI4S increased significantly in 2026, related investment and financing continued to be active, order performance from upstream gene protein synthesis suppliers grew rapidly, and incremental demand is expected to extend downstream.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.